| Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis (NCT05387785) | Angion Biomedica Corp | 2022-06-01 |
| IPF Longitudinal Natural History Study (NCT07560189) | Assiut University | 2022-04-01 |
| Artificial Intelligence (AI) Detection of Incidental Interstitial Opacity on Chest Radiography (NCT07686562) | Chung-Ang University Hospital | 2022-02-01 |
| Inhaled NAC in Treatment of IPF (NCT03720483) | University of Colorado, Denver | 2022-01-01 |
| Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF） (NCT05119972) | Guangdong Raynovent Biotech Co., Ltd | 2021-10-21 |
| Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis (NCT04598919) | National Jewish Health | 2020-11-12 |
| TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis (NCT04589260) | Theravance Biopharma | 2020-10-15 |
| Morphine for Dyspnea in Pulmonary Fibrosis (NCT04497831) | Medical University of Gdansk | 2020-09-21 |
| A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327 (NCT04069143) | Bristol-Myers Squibb | 2019-10-01 |
| A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants (NCT03981094) | Bristol-Myers Squibb | 2019-05-10 |
| To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers (NCT03650075) | Metagone Biotech Inc. | 2019-02-25 |
| A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT03832946) | Galecto Biotech AB | 2019-02-19 |
| The Genetics of Pulmonary Fibrosis (NCT03478553) | University of Colorado, Denver | 2018-01-18 |
| Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial (NCT02874989) | Wake Forest University Health Sciences | 2016-12-16 |
| Short-term Effects of Supplemental Oxygen in Patients With IPF (NCT03050255) | Schön Klinik Berchtesgadener Land | 2016-11-01 |
| Pulmonary Fibrosis Foundation Patient Registry (NCT02758808) | Pulmonary Fibrosis Foundation | 2016-03-29 |
| A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT02538536) | Liminal BioSciences Ltd. | 2015-07-01 |
| Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER) (NCT02013700) | Joshua M Hare | 2013-11-13 |
| Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis (NCT01718990) | University of California, San Francisco | 2012-10-01 |
| Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies (NCT01776398) | Weill Medical College of Cornell University | 2012-08-29 |
| STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT01371305) | Biogen | 2012-07-16 |
| Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide (NCT00162760) | Johns Hopkins University | 2003-10-01 |